Sandy Spring Bank’s Niagen Bioscience NAGE Stock Holding History

Sandy Spring Bank’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$345	Buy	+50	New	+$314	﹤0.01%	1144
2023 Q2	–	Sell	-3,500	Closed	-$5.36K	–	1270
2023 Q1	$5.36K	Hold	3,500	–	–	﹤0.01%	921
2022 Q4	$5.88K	Hold	3,500	–	–	﹤0.01%	902
2022 Q3	$4K	Hold	3,500	–	–	﹤0.01%	972
2022 Q2	$6K	Hold	3,500	–	–	﹤0.01%	931
2022 Q1	$9K	Hold	3,500	–	–	﹤0.01%	885
2021 Q4	$13K	Hold	3,500	–	–	﹤0.01%	861
2021 Q3	$22K	Buy	+3,500	New	+$28.8K	﹤0.01%	747

Other funds holding NAGE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sandy Spring Bank's NAGE Position: Q1 2025 in Review

Sandy Spring Bank opened a new position in Niagen Bioscience (NAGE) in Q1 2025: 50 shares worth $345. The stake represents ﹤0.01% of the portfolio and ranks #1144 among its holdings. This is a return to the name: Sandy Spring Bank previously reported a position in NAGE as recently as Q1 2023.

Sandy Spring Bank first reported a position in NAGE in Q3 2021 and has held it in 8 quarters since. The position peaked at $22K in Q3 2021. 139 funds tracked by Wall St. Rank hold NAGE as of Q1 2025.

Sandy Spring Bank held 50 shares of Niagen Bioscience worth $345 as of Q1 2025.
Niagen Bioscience was a new Sandy Spring Bank position in Q1 2025.
Niagen Bioscience made up ﹤0.01% of Sandy Spring Bank's portfolio in Q1 2025, its #1144 holding.
Sandy Spring Bank first reported a position in Niagen Bioscience in Q3 2021 and has held it in 8 quarters since.
Sandy Spring Bank's Niagen Bioscience position peaked at $22K in Q3 2021.
139 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2025.

Based on Sandy Spring Bank's 13F filing for Q1 2025, filed 12 May 2025.